Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q2

4544.TEDINET S100S6Z0
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥116.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥260.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥134.1bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥1.6bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥17.7bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥1.6bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥22.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥1.6bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥20.7bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥15.6bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥1.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥15.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥284.6bnat 2023-09-30Cons.Assets
Total assets¥297.9bnat 2023-03-31Cons.Assets
Total assets¥287.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥134.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥147.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥150.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥150.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥157.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥37.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥44.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥37.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥44.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥37.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥5.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥15.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥29.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥7.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-322023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-12.332023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥275.522022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥273.872022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥175.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥275.52022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥273.842022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio52.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥3.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥3.1bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥2.8bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥72.4bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥72.3bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥74m
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2023-04-01 → 2023-09-30−¥6.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥33.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥30.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥3.0bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.8bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2023-04-01 → 2023-09-30¥14.0bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2023-04-01 → 2023-09-30¥14.0bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥3m
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2023-04-01 → 2023-09-30¥564m
—segment totalrevenue2023-04-01 → 2023-09-30¥119.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥116.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥3.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥5.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥5.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.5bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥85.1bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥85.0bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥83m
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥40.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥35.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5.0bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥15.7bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-09-30¥13.8bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.8bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥10m
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-09-30¥604m
—segment totalrevenue2022-04-01 → 2022-09-30¥139.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥134.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥5.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥19.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 524
ItemContextValueUnit
Income before income taxesPrior1YTDDuration20717000000JPY
Income before income taxesCurrentYTDDuration-1590000000JPY
Income taxes currentPrior1YTDDuration2909000000JPY
Income taxes currentCurrentYTDDuration1631000000JPY
Income taxes deferredPrior1YTDDuration2227000000JPY
Income taxes deferredCurrentYTDDuration-1398000000JPY
Income taxesPrior1YTDDuration5137000000JPY
Income taxesCurrentYTDDuration232000000JPY
Profit lossPrior1YTDDuration15580000000JPY
Profit lossCurrentYTDDuration-1822000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration15580000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-1822000000JPY
Profit lossPrior1YTDDuration15580000000JPY
Profit lossCurrentYTDDuration-1822000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-1392000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration484000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration6194000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration5142000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration101000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration84000000JPY
Other comprehensive incomePrior1YTDDuration4904000000JPY
Other comprehensive incomeCurrentYTDDuration5711000000JPY
Comprehensive incomePrior1YTDDuration20484000000JPY
Comprehensive incomeCurrentYTDDuration3889000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration20484000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3889000000JPY
Income before income taxesPrior1YTDDuration20717000000JPY
Income before income taxesCurrentYTDDuration-1590000000JPY
Depreciation and amortization ope cfPrior1YTDDuration9118000000JPY
Depreciation and amortization ope cfCurrentYTDDuration10116000000JPY
Amortization of goodwill ope cfPrior1YTDDuration70000000JPY
Amortization of goodwill ope cfCurrentYTDDuration145000000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-736000000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration-1082000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration1153000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration743000000JPY
Decrease increase in trade receivables and contract assets ope cfPrior1YTDDuration5806000000JPY
Decrease increase in trade receivables and contract assets ope cfCurrentYTDDuration-434000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-712000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration504000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-1945000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-4241000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-2025000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-1519000000JPY
Loss gain on step acquisitions ope cfPrior1YTDDuration-758000000JPY
Loss gain on step acquisitions ope cfCurrentYTDDuration－JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-853000000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration1021000000JPY
Decrease increase in other current assets ope cfPrior1YTDDuration-758000000JPY
Decrease increase in other current assets ope cfCurrentYTDDuration-989000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass